自依赖的蛋白质稳定抑制乳腺癌转移
Jayanta Debnath1, Gourish Mondal1
1Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Autophagy
|October 2, 2025
概括
乳腺癌的自缺陷通过通过NBR1-SQSTM1凝聚剂稳定TP63转录因子来促进转移. 准这些凝结物可能会防止癌症扩散,特别是当自功能受损时.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症转移的分子机制
背景情况:
- 宏自/自通常抑制乳腺癌转移,但潜在的分子机制尚未完全理解.
- 自性缺陷与乳腺癌转移潜力的增加有关.
- 生物分子凝聚物形成及其在癌症进展中的作用是新兴的研究领域.
研究的目的:
- 阐明自性缺乏促进乳腺癌转移的分子机制.
- 研究自载荷受体NBR1和SQSTM1在介导转移潜力的作用.
- 在自性缺陷的背景下,确定预防乳腺癌转移的潜在治疗点.
主要方法:
- 在乳腺癌细胞中分析相分离的生物分子凝聚物,其自水平不同.
- 研究NBR1,SQSTM1,ITCH和TP63.3之间的相互作用.
- 评估ITCH封存对TP63稳定性和乳腺癌细胞分化状态的影响.
主要成果:
- 自缺乏导致NBR1-SQSTM1生物分子凝聚物的积累.
- 这些凝结物隔离了E3泛基因酶ITCH,防止TP63的降解.
- 稳定和激活TP63促进了侵略性,基底性差异化状态,增强了转移潜力.
结论:
- 通过稳定TP63.3,NBR1-SQSTM1凝聚剂通过稳定TP63.1驱动自缺陷乳腺癌的转移.
- 由于自功能障碍导致的蛋白质稳定性缺陷会破坏表皮细胞谱系的忠实性,并增加转移潜力.
- 准NBR1-SQSTM1凝聚物是一种潜在的治疗策略,可以抑制转移,特别是在自性缺陷癌症中.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Delivery Pathways to the Lysosome
8.8K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.8K


